Nouvelles Eulerpool ALX Oncology Holdings

ALX Oncology Holdings Actualités des actions

ALX Oncology Holdings est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités ALX Oncology Holdings.

• 12 décembre ·

  Yahoo
  ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at SABCS 2024
• 10 décembre ·

  Yahoo
  ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer
• 21 novembre ·

  Yahoo
  ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
• 14 novembre ·

  Yahoo
  ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer
• 4 novembre ·

  Yahoo
  ALX Oncology Announces November Investor Conference Participation
• 3 novembre ·

  Seeking Alpha
  Warning: ALXO is at high risk of performing badly
• 2 novembre ·

  Seeking Alpha
  Warning: ALXO is at high risk of performing badly
• 1 novembre ·

  Yahoo
  ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
• 31 octobre ·

  Seeking Alpha
  Warning: ALXO is at high risk of performing badly
• 29 octobre ·

  Seeking Alpha
  Warning: ALXO is at high risk of performing badly